286 related articles for article (PubMed ID: 32052378)
1. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.
Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A
Clin Pharmacokinet; 2020 Jul; 59(7):911-925. PubMed ID: 32052378
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Coupling of a Novel
Mian P; Nolan B; van den Anker JN; van Calsteren K; Allegaert K; Lakhi N; Dallmann A
Front Pediatr; 2021; 9():733520. PubMed ID: 34631628
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Yan Y; Wang Q; Wu W; Yi H; Xie F
Pharm Res; 2024 May; 41(5):899-910. PubMed ID: 38684563
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Framework to Predict Maternal-Placental-Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach.
Werdan Romão MA; Pinto L; Cavalli RC; Duarte G; de Moraes NV; Abduljalil K; Moreira FL
J Clin Pharmacol; 2024 May; 64(5):568-577. PubMed ID: 38305718
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.
Schalkwijk S; Buaben AO; Freriksen JJM; Colbers AP; Burger DM; Greupink R; Russel FGM
Clin Pharmacokinet; 2018 Jun; 57(6):705-716. PubMed ID: 28744795
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
8. Methodological Approaches to Evaluate Fetal Drug Exposure.
Bouazza N; Foissac F; Hirt D; Urien S; Benaboud S; Lui G; Treluyer JM
Curr Pharm Des; 2019; 25(5):496-504. PubMed ID: 30892158
[TBL] [Abstract][Full Text] [Related]
9. Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling.
Roelofsen D; van Hove H; Bukkems V; Russel F; Eliesen G; Greupink R
Toxicol In Vitro; 2022 Dec; 85():105471. PubMed ID: 36096459
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
11. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
[TBL] [Abstract][Full Text] [Related]
12. Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.
Mian P; van den Anker JN; van Calsteren K; Annaert P; Tibboel D; Pfister M; Allegaert K; Dallmann A
Clin Pharmacokinet; 2020 Jan; 59(1):97-110. PubMed ID: 31347013
[TBL] [Abstract][Full Text] [Related]
13. Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model.
Conings S; Tseke F; Van den Broeck A; Qi B; Paulus J; Amant F; Annaert P; Van Calsteren K
Toxicol Appl Pharmacol; 2019 May; 370():14-23. PubMed ID: 30849458
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments.
Bukkems VE; van Hove H; Roelofsen D; Freriksen JJM; van Ewijk-Beneken Kolmer EWJ; Burger DM; van Drongelen J; Svensson EM; Greupink R; Colbers A
Clin Pharmacokinet; 2022 Aug; 61(8):1129-1141. PubMed ID: 35579825
[TBL] [Abstract][Full Text] [Related]
16. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
Balhara A; Kumar AR; Unadkat JD
J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
[TBL] [Abstract][Full Text] [Related]
17. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
[TBL] [Abstract][Full Text] [Related]
18. Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model.
Codaccioni M; Brochot C
Toxicol Appl Pharmacol; 2020 Dec; 409():115318. PubMed ID: 33160985
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?
Liu XI; Green DJ; van den Anker JN; Rakhmanina NY; Ahmadzia HK; Momper JD; Park K; Burckart GJ; Dallmann A
Front Pediatr; 2021; 9():723006. PubMed ID: 34733804
[No Abstract] [Full Text] [Related]
20. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
